These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27076246)

  • 1. [Recent progress and perspectives in the field of fibrinolysis].
    Urano T; Suzuki Y
    Rinsho Ketsueki; 2016 Mar; 57(3):333-9. PubMed ID: 27076246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basic knowledge on coagulation and fibrinolysis to understand thrombus-formation machinery].
    Urano T; Suzuki Y
    Nihon Rinsho; 2014 Jul; 72(7):1198-205. PubMed ID: 25163308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutics targeting the fibrinolytic system.
    Lin H; Xu L; Yu S; Hong W; Huang M; Xu P
    Exp Mol Med; 2020 Mar; 52(3):367-379. PubMed ID: 32152451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis].
    Ojiro M
    Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolysis and antifibrinolytic drugs in the growth and spread of tumours.
    Peterson H
    Cancer Treat Rev; 1977 Sep; 4(3):213-7. PubMed ID: 589607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A; Dimitrov D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract]   [Full Text] [Related]  

  • 8. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinolysis modulators].
    Machovich R
    Orv Hetil; 2002 Mar; 143(11):541-5. PubMed ID: 12583322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of endothelial cells fibrinolytic activity by platelets.
    Menashi S; He L; Soria C; Soria J; Thomaidis A; Legrand Y
    Thromb Haemost; 1991 Jan; 65(1):77-81. PubMed ID: 2024242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation and fibrinolytic enzyme systems during and after extracorporeal circulation].
    Goldschmidt B; Böröcz L; Haas M; Büky B
    Thoraxchir Vask Chir; 1970 Dec; 18(6):510-9. PubMed ID: 5275551
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hematologic changes following surgery. II. Blood platelets, blood coagulation and fibrinolysis].
    Bogusz J; Lisiewicz J
    Pol Przegl Chir; 1969 Aug; 41(8):1078-83. PubMed ID: 4898800
    [No Abstract]   [Full Text] [Related]  

  • 16. Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.
    Idell S; Peterson BT; Gonzalez KK; Gray LD; Bach R; McLarty J; Fair DS
    Am Rev Respir Dis; 1988 Nov; 138(5):1282-94. PubMed ID: 3202484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
    Van Leer C; Stutz M; Haeberli A; Geiser T
    Thromb Haemost; 2005 Dec; 94(6):1257-64. PubMed ID: 16411403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator in human megakaryocytes and platelets: immunocytochemical localization, immunoblotting and zymographic analysis.
    Jeanneau C; Sultan Y
    Thromb Haemost; 1988 Jun; 59(3):529-34. PubMed ID: 3142087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis].
    Van de Loo J
    Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.